Skip to main content
Z

ZuChem

ZuChem develops proprietary bioprocesses to manufacture carbohydrates for human health and nutrition. They offer a sustainable, natural alternative to chemical hydrogenation for xylitol production and provide custom synthesis of rare and modified sugars for pharmaceutical research.

Peoria, United StatesFounded 200311200+ followers
Updated 3 months ago

Funding

$150K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional methods for producing xylitol rely on chemical hydrogenation, which presents challenges related to supply chain stability, cost, and environmental impact. Similarly, the synthesis of rare and modified sugars for pharmaceutical applications is often prohibitively expensive and difficult to scale using conventional chemical processes.

Solution

ZuChem develops proprietary bioprocesses to manufacture carbohydrates for human health and nutrition. The company's scalable fermentation process for xylitol offers a sustainable, natural alternative to chemical hydrogenation, addressing historical supply and cost constraints. ZuChem also provides custom synthesis services for rare and modified sugars, enabling their use as building blocks in pharmaceutical research and development. Their technology platform leverages proprietary enzymes, engineered microbial strains, and metabolic engineering systems to create cost-effective and scalable production methods for a range of glycochemicals.

Target Audience

Primary customers include food and beverage manufacturers seeking natural sweeteners, and pharmaceutical and biotechnology companies requiring specialized carbohydrate intermediates for drug discovery and development.

Features

  • Proprietary fermentation process for natural xylitol production, overcoming limitations of chemical hydrogenation.
  • Scalable bioprocesses for the manufacture of various carbohydrates, including polyols and rare sugars.
  • Metabolic engineering and strain development capabilities for optimizing carbohydrate production.
  • Custom synthesis of rare, modified, and activated sugars for pharmaceutical and life science research.
  • Expertise in enzyme conversion and sugar linking technologies.
  • Development of cost-effective production methods for human milk oligosaccharides (HMOs).
This profile is AI-generated and may contain inaccuracies.